Cleveland Clinic Orthopaedic and Rheumatology Care -- Quality Innovation Summit 2

克利夫兰诊所骨科和风湿科护理——质量创新峰会2

基本信息

批准号：
7674443
负责人：
George F Muschler
金额：
$ 1.7万
依托单位：
CLEVELAND CLINIC LERNER COM-CWRU
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-05-01 至 2009-11-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7674443
关键词：
Address Advocate Age American Area Arts Caring Client satisfaction Clinic Collaborations Degenerative polyarthritis Devices Disease Drug Industry Environment Event Evolution Family Federal Government Funding Funding Agency Future Government Government Officials Growth Health Professional Impairment Individual Information Technology Institution Joints Link Measurement Measures Medical Medicine Methodology Metric Modeling Musculoskeletal Musculoskeletal Diseases Orthopedics Osteoporosis Outcome Pain Participant Patients Performance Pharmaceutical Preparations Physicians Population Process Production Protocols documentation Public Health Quality of Care Rheumatoid Arthritis Rheumatology Shapes Site Societies Specialist System Technology Therapeutic United States Vision Visual Vocabulary Writing abstracting bone cost design disability forging innovation interest meetings multidisciplinary patient population patient safety response symposium

项目摘要

DESCRIPTION (provided by applicant): Abstract: The 2009 Cleveland Clinic Orthopaedic and Rheumatology Care - Quality Innovation Summit, May 13-15, 2009, is a 2 1/2 day multidisciplinary conference devoted to exploring the current state-of-the-art in the assessment and management of quality in Musculoskeletal Medicine from the perspective of each of the stakeholders in this process. Musculoskeletal disorders are the leading cause of disability in the United States, with one in every seven Americans afflicted with an impairment of the bones or joints. Each day, millions of Americans endure such conditions as osteoarthritis, rheumatoid arthritis, and osteoporosis, with the resulting pain, disability, and medical expense inflicting tremendous burdens on individuals, families, and society. Moreover, the impact of musculoskeletal conditions is expected to grow as the American population increases and ages in the coming decades. In response to this dramatic growth in patient populations and increase in the complexity of musculoskeletal diseases, the number of new drugs and devices, as well as therapeutic protocols to treat those diseases, has also increased. This evolution in treatment technologies has necessitated a new look at the methodology and metrics for measuring patient outcomes and patient satisfaction. This meeting is the first of its kind in orthopaedics and rheumatology, bringing together physicians, quality management specialists, public health professionals, information technology experts, government officials and patient safety advocates to address the "How and Why" of quality measurement.

描述（申请人提供）：摘要：2009年克利夫兰诊所骨科和风湿病学护理 - 质量创新峰会，2009年5月13日至15日，是一场2 1/2天的多学科会议，致力于探索肌肉骨骼药物质量的评估和管理的最新目前，从肌肉骨骼药物的评估和管理。肌肉骨骼疾病是美国残疾的主要原因，每七个美国人中有一个患有骨骼或关节损害。每天，成千上万的美国人忍受骨关节炎，类风湿关节炎和骨质疏松症，造成疼痛，残疾和医疗费用，给个人，家庭和社会带来巨大负担。此外，随着未来几十年中美国人口的增加和年龄的增长，肌肉骨骼状况的影响预计会增长。为了应对患者人群的这种急剧增长以及肌肉骨骼疾病的复杂性的增加，新药和装置的数量以及治疗这些疾病的治疗方案也有所增加。治疗技术的这种演变需要对衡量患者预后和患者满意度的方法和指标进行新的研究。这次会议是骨科和风湿病学中的第一个会议，将医师，质量管理专家，公共卫生专业人员，信息技术专家，政府官员和患者安全倡导者汇集在一起，以解决质量测量的“如何和原因”。